Home
Research
GloBody
Members
Publications
Links
Book Club
Press Coverage
Contact
More
JUNE 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
december 2021
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in MS
October 2021
COVID-19 vaccine response in people with multiple sclerosis
Summer 2021
Immunogenicity of biologics used in the treatment of moderate to severe psoriasis
summer 2021
Immunogenicity of biologics used in the treatment of inflammatory bowel disease: A review
Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis
July 2020
Mapping the T cell response to COVID-19
june 2020
Detecting and predicting neutralization of Alemtuzumab responses in Multiple Sclerosis.